INDIA —QMS Medical Allied Services has finalized the complete acquisition of Saarathi Healthcare, securing a 100 percent equity interest following the purchase of the remaining 24 percent stake for 142.25 million rupees. This transaction concludes a phased consolidation strategy that commenced in June 2024 when an initial 51 percent share was acquired, subsequently elevated to 76 percent in October 2025.
The full consolidation aligns with the corporate objective of scaling an integrated healthcare delivery framework. By integrating Saarathi Healthcare's competencies in disease management, awareness campaigns, and point-of-care screening with existing operations in diagnostic medical devices and patient service programs, the enterprise intends to establish a comprehensive continuum of patient care.
Founded as an integrated healthcare solutions provider, QMS Medical Allied Services manages diversified operations spanning medical device distribution, preventive health initiatives, and institutional staffing solutions. Saarathi Healthcare contributes specialized digital-physical engagement platforms tailored for long-term therapeutic monitoring and patient support.
This structural consolidation carries significant operational relevance for pharmaceutical manufacturers, healthcare providers, and institutional partners seeking unified patient support systems. By absorbing specialized screening and management assets, the parent organization strengthens its competitive positioning within the preventive healthcare and clinical services sector across the domestic market.
The transaction occurs during a period of corporate expansion characterized by a migration to the NSE Mainboard in June 2026 and an exclusive distribution partnership with HEINE Optotechnik. Management has outlined institutional growth projections aimed at crossing the 50000 million rupees revenue benchmark by fiscal year 2029 through the scaling of core product verticals and integrated service divisions.
